Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Quest, Pressure Biosciences, and More

Premium

Quest Diagnostics has promoted Tracy Cinco-Abela to be VP and treasurer. Before Cinco-Abela joined Quest in 2007 she worked for the General Motors treasurer's office, and at Quest she most recently was the company's assistant treasurer.


Pressure BioSciences has appointed Mickey Urdea to serve on its board of directors, filling the seat left by Wayne Fritzsche, who resigned last week to pursue a full-time management position at the company.

Urdea, who also will lead PBI's scientific advisory board, founded and is a managing partner of the biotech consulting firm Halteres Associates. He also founded and was CEO of Tethys Bioscience, and he helped found and served as chairman of the Catalysis Foundation for Health.


Nanosphere said this week in its fourth-quarter financial report that it has promoted Michael McGarrity to succeed William Moffitt as its new president and CEO.

The company also said it has appointed Sheli Rosenberg, Michael Ward, and McGarrity to serve on its board of directors, while Moffitt, William White, Mark Slezak, and Roy Davis have all resigned from the board. Rosenberg, who served on Nanosphere's board from 2002 to 2012, will be the new chair of the board.

McGarrity previously was VP of sales and marketing and chief commercial officer, and he has 24 years of experience in the medical devices industry, including 13 years at Stryker.


Danaher said in a filing with the Securities and Exchange Commission that Mortimer Caplin has decided not to stand for reelection to the company's board of directors and will retire after the firm's annual meeting in May.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.